Disease severity associated with cystic fibrosis mutations deltaF508 and S549R[T-G]
AbstractWe compared the clinical severity associated with the two cystic fibrosis [CF] mutations S549R[T[R]G] and deltaF508. Clinical and biochemical variables of CF were compared in two age- and sex-matched groups of CF children in the United Arab Emirates [UAE]. The clinical severity of mutations S549R[T[R]G] and delta F508 showed comparable patterns, with very low Shwachman scores and high sweat chloride levels. We conclude that patients homozygous for the CF mutations deltaF508 and S549R[T[R]G] have a severe clinical presentation and illness and are indistinguishable on clinical grounds
Dawson, K.P., Frossard, P.M. & Al Awar, B. (2001). Disease severity associated with cystic fibrosis mutations deltaF508 and S549R[T-G]. http://www.who.int/iris/handle/10665/119115
EMHJ - Eastern Mediterranean Health Journal, 7 (6), 975-980, 2001
MetadataShow full item record
Showing items related by title and MeSH subject.
Implementation of cystic fibrosis services in developing countries : report of a Joint WHO/International Cystic Fibrosis (Mucoviscidosis Association Meeting Joint WHO/International Cystic Fibrosis (Mucoviscidosis) Association Meeting 1995: Manama, Bahrain); WHO Human Genetics Programme (WHO/HGN/ICF(M)A/WG/95.6. Unpublished, 1995)
Guidelines for the diagnosis and management of cystic fibrosis / prepared by Fernando A. de Abreu e Silva, John A. Dodge ; in cooperation with the WHO Human Genetics Programme and the International Cystic Fibrosis (Mucoviscidosis) Association Silva, Fernando A. de Abreu; Dodge, John A; WHO Human Genetics Programme; International Cystic Fibrosis (Mucoviscidosis Association) (WHO/HGN/ICF(M)A/GL/96.2. Unpublished, 1996)